Associate Director Forecasting US Oncology
abbvie
Umowa o pracęPełny etatOpublikowano 2 września 2026
Źródło: About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.
The primary objective of this position is to lead the volume and sales forecast analytical process for Etenta, AbbVie's Multiple Myeloma (MM) franchise. Etenta is a 100% AbbVie-owned asset, and this role is built to scale with the franchise: beyond the launch indication, the forecast scope is expected to expand across additional Etenta indications (e.g., earlier lines of therapy) and additional MM pipeline products as they advance toward launch.
Specifically, this position is responsible for developing accurate and timely projections of commercial product volumes for Plan, Update, LBE, LRP, Portfolio, and Actual submissions, as well as providing decision-making support and recommendations to Senior Management. As the MM portfolio grows, the role establishes the forecasting methodology, tools, and cadence that new indications and assets will inherit — making this a franchise-building position, not a single-product one.
The Associate Director builds and maintains deep knowledge of the business through focused partnership with internal AbbVie functions, including Marketing & Sales Management, Marketing Analytics & Business Insights (MABI), Market Access, and Commercial Finance.
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.
The primary objective of this position is to lead the volume and sales forecast analytical process for Etenta, AbbVie's Multiple Myeloma (MM) franchise. Etenta is a 100% AbbVie-owned asset, and this role is built to scale with the franchise: beyond the launch indication, the forecast scope is expected to expand across additional Etenta indications (e.g., earlier lines of therapy) and additional MM pipeline products as they advance toward launch.
Specifically, this position is responsible for developing accurate and timely projections of commercial product volumes for Plan, Update, LBE, LRP, Portfolio, and Actual submissions, as well as providing decision-making support and recommendations to Senior Management. As the MM portfolio grows, the role establishes the forecasting methodology, tools, and cadence that new indications and assets will inherit — making this a franchise-building position, not a single-product one.
The Associate Director builds and maintains deep knowledge of the business through focused partnership with internal AbbVie functions, including Marketing & Sales Management, Marketing Analytics & Business Insights (MABI), Market Access, and Commercial Finance.
